Phase II AutoImmune Hepatitis

NCT03593460 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped BioIncept changed the focus of future drug development

Conditions

Hepatitis, Autoimmune

Interventions

DRUG: Synthetic PreImplantation Factor

Sponsor

Christopher O'Brien, MD

Collaborators

[object Object]